Lori Kobayashi Email & Phone Number

Maryland, United States

Gaithersburg, Maryland, United States

Project Manager for new consumables on U-PLEX, V-PLEX and R-PLEX

Rockville, MD

Gaithersburg

Assay Development Scientist lead on MSD's two newest V-PLEX (human) products: TH17 Panel 1 and Cytokine Panel 2Responsible for new assay development from feasibility to launch (Development, Verification, Validation) on the MSD V-PLEX and U-PLEX platforms. Responsible for supervising a team of Research Associates, creating a timeline, creating and.

Naval Medical Research Center-Frederick

Part of the Biological Defense Research Directorate (BDRD) supporting Global Emerging Infections Surveillance & Response System programs (GEIS) and global biological Defense Threat Reduction Agency (DTRA) programs. Trained on implementation of ISO 17043 and ISO 17025.Designed and implemented a training program for laboratory technicians in partner.

At Life Technologies Frederick

* Developed ELISA assays to test raw material quality: ascites for PSSAs (Phospho-site specific Antibodies) and monoclonal antibodies from tissue culture supernatant. * Optimized tissue culture workflow and wrote SOPs for large scale monoclonal antibody development under ISO/FDA standards* Developed and performed a troubleshooting protocol for the antibody.

Built, developed, trained and led a team of 5 scientists developing molecular based assays for genotyping and assay troubleshooting (PCR, ELISA, Luminex, Line blot, Real-time PCR, High resolution melt curve).

Evaluated and developed a novel magnetic bead based assay for purification of nucleic acids from cervical cells.Initiated an automated solution for magnetic bead based purification from cervical samples. Oversaw the evaluation of new technologies and applications and training team members.

Developed cell-based apoptosis assays using Meso Scale Discovery proprietary technology.

Managed the purification of membrane proteins from mammalian cells and bacteria using immunoprecipitation and column purification for HIV vaccine development.

Designed high-throughput screening assays for cancer and HIV targets using different robotic machines to manipulate 96 well plates.

Designed and optimized assays PCR, DNA purification, analysis of transient and stable transfection, construction of mammalian expression vectors, and assaying for protein expression from transfected cells.